article thumbnail

Introducing the Borderline Personality Disorder Inventory

Psychiatric Times

Ruffalo, MSW, DPsa Key Takeaways The BPD-I™ is a 25-item questionnaire designed to screen for core features of BPD, reflecting a psychodynamic understanding.

article thumbnail

Exploring NMDA Antagonists for MDD

Psychiatric Times

News Media Peer Exchange Case-Based Psych Perspectives Clinical Case Collective Insights Peers & Perspectives Slideshows Videos Conferences Conference Coverage Conference Listing Publication Psychiatric Times Job Board CME/CE Partners Editorial Resources Between the Lines Expert Perspectives Clinical Consult Clinical Scales Interactive Tools Partner (..)

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

COMP360 Psilocybin for Treatment-Resistant Depression: Positive Phase 3 Efficacy Data

Psychiatric Times

News Media Around the Practice Between the Lines PsychView Expert Perspectives Case-Based Psych Perspectives Clinical Case Collective Dialogues Payer-Provider Perspective Slideshows Videos Viewpoints Conferences Conference Coverage Conference Listing Publication Psychiatric Times Job Board CME/CE Partners Editorial Resources Clinical Consult Clinical (..)

article thumbnail

sNDA Submitted: Lumateperone for the Prevention of Relapse in Schizophrenia

Psychiatric Times

News Media Peer Exchange Case-Based Psych Perspectives Clinical Case Collective Insights Peers & Perspectives Slideshows Videos Conferences Conference Coverage Conference Listing Publication Psychiatric Times Job Board CME/CE Partners Editorial Resources Between the Lines Expert Perspectives Clinical Consult Clinical Scales Interactive Tools Partner (..)

article thumbnail

Successfully Prescribing MAOIs for Depression

Psychiatric Times

SHOW MORE In this CME article, discover effective strategies for prescribing MAOIs in treating major depressive disorder. HOW TO CLAIM CREDIT Once you have read the article, please use the following URL to evaluate and request credit: [link]. Clinicians should weigh benefits and risks collaboratively with patients.

article thumbnail

Tardive Dyskinesia: Treat Functional Impairment, Not the AIMS Score

Psychiatric Times

Download Issue PDF Articles in this issue Tardive Dyskinesia: Treat Functional Impairment, Not the AIMS Score Celebrating 40 Years, A Midway Check-In Preparing for the Future: The Psychiatric Workforce Facts Over Fiction: The Current State of Psychiatry Make America Healthy Again—What About Psychiatry? J Clin Psychiatry.

article thumbnail

The Psychiatric Pipeline in Review: Quarter 2, 2025

Psychiatric Times

Learn more in this exclusive article. Cobenfy failed to meet the primary endpoint in a phase 3 trial for schizophrenia, but showed numerical improvement, warranting further investigation. SHOW MORE What disease states are most prominently featured in recent research?